Pediatric Beta Blocker Therapy: A Comprehensive Review of Development and Genetic Variation to Guide Precision-Based Therapy in Children, Adolescents, and Young Adults
Beta adrenergic receptor antagonists, known as beta blockers, are one of the most prescribed medications in both pediatric and adult cardiology. Unfortunately, most of these agents utilized in the pediatric clinical setting are prescribed off-label. Despite regulatory efforts aimed at increasing ped...
Main Authors: | Mollie Walton, Jonathan B. Wagner |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-03-01
|
Series: | Genes |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4425/15/3/379 |
Similar Items
-
Repurposing beta-blockers for combinatory cancer treatment: effects on conventional and immune therapies
by: Rachel Massalee, et al.
Published: (2024-01-01) -
Trial watch: beta-blockers in cancer therapy
by: Killian Carnet Le Provost, et al.
Published: (2023-12-01) -
Beta-blocker Rebound Phenomenon in an Adolescent with Graves’ Disease
by: Ahmet Anık
Published: (2022-12-01) -
PRACTICE OF PRESCRIBING BETA-BLOCKERS AND ITS COMPLIANCE WITH CLINICAL GUIDELINES ACCORDING TO TWO REGISTERS OF CARDIOVASCULAR DISEASES
by: S. Yu. Martsevich, et al.
Published: (2016-06-01) -
Beta-Blockers and Cancer: Where Are We?
by: Rita Peixoto, et al.
Published: (2020-05-01)